Dallah Health posts higher net profit at SAR 136.6m for 2013
31/12/2013
Argaam Exclusive
View other reports
Dallah Health Holding Co., active in the operation and management of hospitals and medical clinics, reported SAR 136.6m net profit at the end of 2013, a 2.5% increase compared to last year, as shown in the following table:
Financials (M)
| Item | 2012 | 2013 | Change |
|---|---|---|---|
| Revenues | 636.86 | 749.65 | 17.7 % |
| Gross Income | 286.87 | 327.45 | 14.1 % |
| Operating Income | 130.75 | 137.53 | 5.2 % |
| Net Income | 133.36 | 136.63 | 2.5 % |
| Average Shares | 90.00 | 90.00 | - |
| EPS (Riyals) | 1.48 | 1.52 | 2.5 % |
Compared With The
Current Quarter Comparison (M)
| Item | Q4 2012 | Q4 2013 | Change |
|---|---|---|---|
| Revenues | 179.43 | 211.05 | 17.6 % |
| Gross Income | 81.51 | 95.71 | 17.4 % |
| Operating Income | 32.18 | 48.06 | 49.3 % |
| Net Income | 34.37 | 52.11 | 51.6 % |
| Average Shares | 90.00 | 90.00 | - |
| EPS (Riyals) | 0.38 | 0.58 | 51.6 % |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2013 | 183.73 | 19.3 % | 84.40 | 15.9 % | 38.39 | 1.0 % |
| Q2 2013 | 187.79 | 16.4 % | 80.68 | 9.4 % | 30.19 | (20.9 %) |
| Q3 2013 | 167.08 | 17.4 % | 66.67 | 13.0 % | 21.95 | (2.0 %) |
| Q4 2013 | 211.05 | 17.6 % | 95.71 | 17.4 % | 48.06 | 49.3 % |
| 2013 | 749.65 | 17.7 % | 327.45 | 14.1 % | 137.53 | 5.2 % |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
|---|---|---|---|---|---|---|
| Q1 2013 | 39.04 | 2.8 % | 0.43 | - | 39.04 | 0.43 |
| Q2 2013 | 23.64 | (36.3 %) | 0.26 | - | 23.64 | 0.26 |
| Q3 2013 | 21.84 | (8.7 %) | 0.24 | - | 21.84 | 0.24 |
| Q4 2013 | 52.11 | 51.6 % | 0.58 | - | 52.11 | 0.58 |
| 2013 | 136.63 | 2.5 % | 1.52 | - | 136.63 | 1.52 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2013 | 44.79 % | 24.18 % | 20.16 % |
| Q2 2013 | 44.08 % | 22.36 % | 17.45 % |
| Q3 2013 | 43.63 % | 21.80 % | 16.56 % |
| Q4 2013 | 43.68 % | 23.30 % | 18.23 % |
| 2013 | 43.68 % | 23.16 % | 18.23 % |
Compared With The
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2013 | 90.00 | 1.49 | 1.49 | 12.83 |
| Q2 2013 | 90.00 | 1.34 | 1.34 | 12.37 |
| Q3 2013 | 90.00 | 1.32 | 1.32 | 12.64 |
| Q4 2013 | 90.00 | 1.52 | 1.52 | 13.22 |
Multiple Ratios (End of Period Price)
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2013 | 23.15 | 23.15 | 2.70 |
| Q2 2013 | 26.26 | 26.26 | 2.85 |
| Q3 2013 | 26.93 | 26.93 | 2.82 |
| Q4 2013 | 26.15 | 26.15 | 3.00 |
Business Segments (Million)
Q4 2013
| Period | Medical Services | Medicine and Pharmaceutical Products |
|---|---|---|
| Q1 2013 | 169.97 | 13.76 |
| Q2 2013 | 168.24 | 19.56 |
| Q3 2013 | 158.17 | 8.92 |
| Q4 2013 | 192.80 | 18.25 |
| Current | |
| Market Cap (M Riyal) | 14,945.04 |
| Enterprise Value (EV) (M) | 16,864.64 |
| Shares Outstanding ((M)) | 97.68 |
| EPS ( Riyal) (TTM) | 4.82 |
| Book Value (BV) ( Riyal) | 34.96 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 31.73 |
| P/E (TTM) | 31.73 |
| Price/book | 4.38 |
| Return on Average Assets (%) (TTM) | 7.5 |
| Return on Average Equity (%) (TTM) | 14.3 |
Share Price
Dallah Healthcare Co. (DALLAH HEALTH)
Follow us on
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}